Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-11

Clinical Trial Update: A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ferumoxytol with placebo for iron deficiency anemia completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: AMAG Pharmaceuticals, Inc. | Conditions: Iron Deficiency Anemia | Phase 3 | Status: COMPLETED | Results posted: 2018-06-11